Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2023
New Zealand Pharmaceutical Schedule - 1 December 2023
1 December 2023 - The December 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 13 Sep 2023
Treatment options for people with glioma, a type of brain cancer
13 September 2023 - BMS, the supplier of lomustine, a treatment used for a type of brain cancer called glioma, is ...
Posted by Michael Wonder on 05 Sep 2023
Oncologists pen open letter to PHARMAC asking for more life-saving cancer drugs
5 September 2023 - Drug buying agency PHARMAC is not moving fast enough, says a gut cancer patient paying more ...
Posted by Michael Wonder on 27 Aug 2023
PHARMAC announcement of more blood cancer medicines welcomed
27 August 2023 - Myeloma New Zealand is welcoming Pharmac's announcement of more blood cancer medicines, but says the country is ...
Posted by Michael Wonder on 24 Aug 2023
PHARMAC seeking bids from suppliers for multiple myeloma treatments
24 August 2023 - PHARMAC is seeking bids from suppliers for two medicines, lenalidomide and pomalidomide, for use in the ...
Posted by Michael Wonder on 22 Aug 2023
Suggestions Nat's cancer drug funding promise has put PHARMAC in a difficult position
22 August 2023 - It's being suggested National's cancer drug funding promise has put PHARMAC in a difficult position. ...
Posted by Michael Wonder on 21 Aug 2023
National to roll back free prescription fees to pay for 13 cancer treatments
21 August 2023 - The National Party wants to bring back the $5 prescription fee for those who can afford ...
Posted by Michael Wonder on 11 Aug 2023
PHARMAC proposes widening access to a brain cancer treatment to help reduce the impact of a discontinuation
11 August 2023 - PHARMAC is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type ...
Posted by Michael Wonder on 11 May 2023
Ovarian cancer: Bay of Plenty mother spends more than $130,000 on treatments
12 May 2023 - Four cancer treatments in three years: $132,775. ...
Posted by Michael Wonder on 01 Apr 2023
New Zealand Pharmaceutical Schedule - 1 April 2023
1 April 2023 The April 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 12 Mar 2023
‘When’s our turn?’ PHARMAC's new funding won't cover breast cancer fighter's $100k bill
13 March 2023 - Hayley Steele has a hefty price tag on her life, one worth almost $100,000. ...
Posted by Michael Wonder on 07 Mar 2023
PHARMAC funds two new treatments for lung cancer
7 March 2023 - PHARMAC has announced the funding of two new medicines - pembrolizumab (Keytruda) and atezolizumab (Tecentriq) for people ...
Posted by Michael Wonder on 03 Mar 2023
'Death sentence' for mum with skin cancer without $100k for the drugs she needs
3 March 2023 - Jen Rowlands, 43, faces certain death from terminal cancer without a specific drug that could radically improve ...
Posted by Michael Wonder on 15 Dec 2022
PHARMAC consulting on two new medicines for lung cancer
16 December 2022 - PHARMAC has reached provisional agreements with two different suppliers to fund two medicines to treat New Zealanders ...
Posted by Michael Wonder on 11 Dec 2022
Miracle medicines: a cancer specialist sends a message to PHARMAC
11 December 2022 - Let's make one thing crystal clear: effective chemotherapeutic drugs make a tremendous difference to survival outcomes ...